Newbridge Financial Services Group, Inc. Ginkgo Bioworks Holdings, Inc. Transaction History

Newbridge Financial Services Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 11, 2024	SELL	$0.28 - $1.16 $560 - $2,320	-2,000 Reduced 14.29%	12,000 $3,000
Q1 2024 Apr 24, 2024	BUY	$1.06 - $1.67 $12,720 - $20,040	12,000 Added 600.0%	14,000 $16,000
Q3 2023 Oct 17, 2023	SELL	$1.61 - $2.54 $11,270 - $17,780	-7,000 Reduced 77.78%	2,000 $3,000
Q2 2023 Jul 21, 2023	SELL	$1.14 - $1.95 $1,140 - $1,950	-1,000 Reduced 10.0%	9,000 $16,000
Q1 2023 Apr 18, 2023	BUY	$1.2 - $2.19 $10,800 - $19,710	9,000 Added 900.0%	10,000 $13,000
Q2 2022 Jul 15, 2022	SELL	$2.2 - $4.2 $6,094 - $11,634	-2,770 Reduced 73.47%	1,000 $2,000
Q1 2022 Apr 26, 2022	BUY	$2.83 - $8.69 $7,839 - $24,071	2,770 Added 277.0%	3,770 $15,000
Q4 2021 Jan 19, 2022	SELL	$8.31 - $14.92 $4,155 - $7,460	-500 Reduced 33.33%	1,000 $8,000
Q3 2021 Oct 27, 2021	BUY	$9.15 - $13.28 $13,725 - $19,920	1,500 New	1,500 $17,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.